IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER

@article{Baum1983IMPROVEDSA,
  title={IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER},
  author={Michael J. Baum and John A. Dossett and J. S. Patterson and F. G. Smiddy and A. J. Wilson and D. Richards and Diana Brinkley and K. Mcpherson and R. D. Rubens and Basil A. Stoll and Julia Cathryn Lea and S. H. Ellis},
  journal={The Lancet},
  year={1983},
  volume={322}
}

General Principles of Medical Cancer Treatment

  • A. Huñis
  • Medicine, Biology
    Journal of Internal Medicine and Emergency Research
  • 2022
TLDR
Stem cell therapy has brought promising efficacy in regenerating and repairing diseased or damaged tissues by targeting both primary and metastatic cancer foci, and nanoparticles brought new diagnostic and therapeutic options.

Tamoxifen – Lieferengpass: Eine Stellungnahme der Fachgesellschaft

  • Senologie - Zeitschrift für Mammadiagnostik und -therapie
  • 2022

Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team

  • V. Jordan
  • Medicine
    Breast Cancer Research and Treatment
  • 2021
TLDR
This retrospective, about a single “mobile” laboratory in six locations on two continents, is intended as a case study in discovery for trainees and junior faculty in the medical sciences and follows the unanticipated discoveries when PhD students “get the wrong answer.

Estimated Projection of US Cancer Incidence and Death to 2040

TLDR
The results estimate that leading cancer incidences and deaths in the US will be notably different in the year 2040 compared with current rankings.

Adjuvant Systemic Therapy in Breast Cancer

  • S. GoldfarbW. Zhi
  • Medicine, Biology
    Oncoplastic and Reconstructive Breast Surgery
  • 2019
TLDR
Systemic adjuvant therapy including endocrine therapy, chemotherapy, and HER2-targeted therapy are discussed including endocrinology, radiation, and chemotherapy for patients with early-stage breast cancer.

Projections in Breast and Lung Cancer Mortality among Women: A Bayesian Analysis of 52 Countries Worldwide.

TLDR
The mortality for lung and breast cancer is higher in high- income countries than in middle-income countries; lung cancer mortality is lower in the latter because the tobacco epidemic is not yet widespread; due to these observed characteristics of lung cancer, primary prevention should still be a key factor to decrease lung cancer deaths.

Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trial

TLDR
Two years of adjuvant tamoxifen resulted in a sustained reduction in mortality in pre- and postmenopausal high-risk breast cancer patients with long-term follow-up data.

Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975–2013

In recent decades, management of prostate and breast cancer patients has changed considerably. The purpose of our study is to interpret patterns of prostate and breast cancer incidence and mortality
...

References

SHOWING 1-3 OF 3 REFERENCES

Regression Models and Life-Tables

The analysis of censored failure times is considered. It is assumed that on each individual arc available values of one or more explanatory variables. The hazard function (age-specific failure rate)

Statistics: the problem of examining accumulating data more than once.

A RECURRING decision that has to be made in planning a controlled clinical trial of a new treatment is the size of the patient sample necessary. In this decision, a major determinant is ethical, fo...

Sounding board. Risks of correcting the risks of coronary disease and stroke with drugs.

  • M. Oliver
  • Medicine
    The New England journal of medicine
  • 1982
TLDR
It has been assumed that the risks associated with drug treatment are low because they relate mostly to predictable minor side effects or idiosyncratic reactions, but when reactions include increased morbidity and mortality, a reappraisal is necessary.